ES2139247T3 - Derivados de 6-polifluoralcoxi y de 6-polifluoralquilo-2-aminobenzotiazoles. - Google Patents

Derivados de 6-polifluoralcoxi y de 6-polifluoralquilo-2-aminobenzotiazoles.

Info

Publication number
ES2139247T3
ES2139247T3 ES95935997T ES95935997T ES2139247T3 ES 2139247 T3 ES2139247 T3 ES 2139247T3 ES 95935997 T ES95935997 T ES 95935997T ES 95935997 T ES95935997 T ES 95935997T ES 2139247 T3 ES2139247 T3 ES 2139247T3
Authority
ES
Spain
Prior art keywords
pct
polifluoralquilo
polifluoralcoxi
aminobenzotiazoles
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95935997T
Other languages
English (en)
Inventor
Philip Chapelle
Claude Gaillard
Patrick Jimonet
Erik Louvel
Michel Martinet
Serge Mignani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Application granted granted Critical
Publication of ES2139247T3 publication Critical patent/ES2139247T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

COMPUESTOS DE FORMULA (I), EN LA QUE R REPRESENTA UN RADICAL POLIFLUOROALCOXI O POLIFLUOROALQUILO Y BIEN R{SUB,1 REPRESENTA UN ATOMO DE HIDROGENO O BIEN R{SUB,2} REPRESENTA UN RADICAL HIDROXI, O BIEN R{SUB,1} REPRESENTA UN RADICAL HIDROXI Y R{SUB,2} REPRESENTA UN ATOMO DE HIDROGENO, SUS SALES, SU PREPARACION Y LOS MEDICAMENTOS QUE LOS CONTIENEN.
ES95935997T 1994-10-26 1995-10-23 Derivados de 6-polifluoralcoxi y de 6-polifluoralquilo-2-aminobenzotiazoles. Expired - Lifetime ES2139247T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9412796A FR2726271B1 (fr) 1994-10-26 1994-10-26 Derives de 6-polyfluoroalcoxy-2-aminobenzothiazole

Publications (1)

Publication Number Publication Date
ES2139247T3 true ES2139247T3 (es) 2000-02-01

Family

ID=9468224

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95935997T Expired - Lifetime ES2139247T3 (es) 1994-10-26 1995-10-23 Derivados de 6-polifluoralcoxi y de 6-polifluoralquilo-2-aminobenzotiazoles.

Country Status (12)

Country Link
US (1) US5795903A (es)
EP (1) EP0788491B1 (es)
JP (1) JP3882198B2 (es)
AT (1) ATE187169T1 (es)
AU (1) AU3809095A (es)
DE (1) DE69513679T2 (es)
DK (1) DK0788491T3 (es)
ES (1) ES2139247T3 (es)
FR (1) FR2726271B1 (es)
GR (1) GR3032022T3 (es)
WO (1) WO1996013492A1 (es)
ZA (1) ZA958861B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824662A (en) 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
PL332413A1 (en) 1996-09-27 1999-09-13 Guilford Pharm Inc Compositions containing inhibitors of naaladase as well as methods of treating glutamatic anomaly and influencing neuronic functions among animals
FR2774592B1 (fr) * 1998-02-06 2000-03-17 Rhone Poulenc Rorer Sa Application du 2-amino-6-trifluoromethoxybenzothiazole pour la prevention ou le traitement des dysfonctionnements du cervelet
JP2005512957A (ja) * 2001-08-13 2005-05-12 マックス−プランク−ゲゼルシャフト ツール フェルデルンク デル ヴィッセンシャフテン エー．ファウ． ポリｑ−凝集の阻害剤
EP1620413A2 (en) * 2003-04-30 2006-02-01 Cytokinetics, Inc. Compounds, compositions, and methods
WO2005077343A2 (de) * 2004-02-11 2005-08-25 Max-Delbrück-Centrum für Molekulare Medizin Neue arzneimittel und diagnostische zusammensetzungen für behandlung und diagnose von neurodegenerativen erkrankungen und amyloid-krankheiten
BR112019020464A2 (pt) 2017-03-30 2020-04-28 Xw Laboratories Inc. compostos derivados de heteroarila bicíclica, composição farmacêutica compreendendo os ditos compostos, adesivo transdérmico compreendendo a dita composição e uso terapêutico dos compostos e composição

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492258A1 (fr) * 1980-10-17 1982-04-23 Pharmindustrie Nouveau medicament a base d'amino-2 trifluoromethoxy-6 benzothiazole
US5236940A (en) * 1988-12-15 1993-08-17 Rhone-Poulenc Sante Pharmaceutical compositions, 2-benzothiazolamine derivatives, and their preparation
FR2649701B2 (fr) * 1988-12-15 1991-11-22 Rhone Poulenc Sante Derives d'imino-2 benzothiazoline, leurs procedes de preparation et les medicaments les contenant
ES2043070T3 (es) * 1988-12-15 1993-12-16 Rhone Poulenc Sante Procedimiento para la preparacion de derivados de la benzotiazolamina-2.

Also Published As

Publication number Publication date
FR2726271B1 (fr) 1996-12-06
ZA958861B (en) 1996-05-09
GR3032022T3 (en) 2000-03-31
ATE187169T1 (de) 1999-12-15
DE69513679T2 (de) 2000-06-21
FR2726271A1 (fr) 1996-05-03
EP0788491A1 (fr) 1997-08-13
DK0788491T3 (da) 2000-05-08
JPH10508014A (ja) 1998-08-04
US5795903A (en) 1998-08-18
DE69513679D1 (de) 2000-01-05
WO1996013492A1 (fr) 1996-05-09
AU3809095A (en) 1996-05-23
EP0788491B1 (fr) 1999-12-01
JP3882198B2 (ja) 2007-02-14

Similar Documents

Publication Publication Date Title
DK0588869T3 (da) Røntgenkontrastmiddel
HUT77925A (hu) Dihidrobenzofuránok, azokat tartalmazó gyógyászati készítmények és eljárás előállításukra
ATE207902T1 (de) Cyclische amidderivate als schutzmittel gegen ultraviolettstrahlung
PT91574A (pt) Procede de preparation de n-cycloalkyle benzyamines utiles comme medicaments
BR9509970A (pt) Composto
DK0788491T3 (da) 6-Polyfluoralkoxy- og 6-polyfluoralkyl-2-aminobenzothiazol-derivater
IT1196423B (it) Benzotiazolin-composti
FI923679A0 (fi) Ny b-fenylisoserinderivat, dess framstaellning och anvaendning.
HUT77768A (hu) N-szubsztituált azabicikloheptánszármazékok, eljárás előállításukra és alkalmazásuk
DE69512208D1 (de) Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren
ZA9429B (en) Pyrrolidine derivatives their preparation and medicaments containing them
AU7899891A (en) Compounds for the treatment of age-related memory impairment and other cognitive disorders
MX9101948A (es) Composicion farmaceutica que contiene derivados de tiazoloisoindolinona
ES2087567T3 (es) Derivados antibioticos de 7'-amino-naftazarina.
ATE155791T1 (de) Etoposid-derivate, ihre herstellung, ihre verwendung als medikament und ihre verwendung zur herstellung eines antikrebsmittels
DE69131353D1 (de) Indolderivate
ATE205853T1 (de) Streptograminderivate, ihre herstellung und sie enthaltende pharmazeutische zubereitungen
DE69919191D1 (de) Heilmittel für die stenose des rückenmarkkanals
ATE79752T1 (de) Verwendung von chromanderivaten zur herstellung eines medikamentes zur behandlung von depressiven zustaenden.
FI915928A0 (fi) Foerbaettrat foerfarande foer fram- staellning av ketonfoerendringar.
AU4544096A (en) New derivatives of glycylanilides, preparation and therapeutical application

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 788491

Country of ref document: ES